Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Colleoni

Showing results (41-50 of 178) with videos related to

Pageof 18
Sort By:
Oncology|January 1, 1992
Mitoxantrone in patients affected by hepatocellular carcinoma with unfavorable prognostic factorsM Colleoni, F Nole, M Di Bartolomeo, et al.
International Journal of Oncology|May 3, 2011
A randomized phase II trial of cisplatinum plus mitomycin-C plus vinorelbine and carboplatin plus vinorelbine in advanced non-small cell lung cancerM Colleoni, G Vicario, F Pancheri, et al.
Anticancer Research|September 1, 1996
Double modulation with methotrexate and L-leucovorin of weekly 24- hour fluorouracil infusion in fluorouracil-refractory colorectal cancerM Colleoni, P Nelli, G Vicario, et al.
Tumori|November 1, 1996
Phase II study of oral L-leucovorin, 120-hour fluorouracil infusion and carboplatin in advanced pancreatic cancerM Colleoni, P Nelli, G Vicario, et al.
Tumori|May 1, 1997
Intermittent continuous infusion of fluorouracil and low-dose oral leucovorin in pretreated breast cancer: a pilot studyM Colleoni, G Vicario, P Nelli, et al.
Oncology Reports|May 20, 2011
Weekly carboplatin in elderly patients with advanced ovarian cancerM Colleoni, G Sgarbossa, P Nelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Adjuvant chemoendocrine therapy in postmenopausal breast cancer: cyclophosphamide, methotrexate, and fluorouracil dose and schedule may make a difference. International Breast Cancer Study GroupA Goldhirsch, A S Coates, M Colleoni, et al.
Journal of Cellular Biochemistry|August 31, 2001
Nitroxide TEMPOL impairs mitochondrial function and induces apoptosis in HL60 cellsE Monti, R Supino, M Colleoni, et al.
Tumori|August 31, 1992
Reversal of resistance to doxifluridine and fluorouracil in metastatic colorectal cancer: the role of high-dose folinic acidM Colleoni, E Bajetta, F de Braud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 1998
Adding adjuvant CMF chemotherapy to either radiotherapy or tamoxifen: are all CMFs alike? The International Breast Cancer Study Group (IBCSG)A Goldhirsch, M Colleoni, A S Coates, et al.
Pageof 18

Showing results (41-50 of 178) with videos related to

Sort By:
Pageof 18
Oncology|January 1, 1992
Mitoxantrone in patients affected by hepatocellular carcinoma with unfavorable prognostic factorsM Colleoni, F Nole, M Di Bartolomeo, et al.
International Journal of Oncology|May 3, 2011
A randomized phase II trial of cisplatinum plus mitomycin-C plus vinorelbine and carboplatin plus vinorelbine in advanced non-small cell lung cancerM Colleoni, G Vicario, F Pancheri, et al.
Anticancer Research|September 1, 1996
Double modulation with methotrexate and L-leucovorin of weekly 24- hour fluorouracil infusion in fluorouracil-refractory colorectal cancerM Colleoni, P Nelli, G Vicario, et al.
Tumori|November 1, 1996
Phase II study of oral L-leucovorin, 120-hour fluorouracil infusion and carboplatin in advanced pancreatic cancerM Colleoni, P Nelli, G Vicario, et al.
Tumori|May 1, 1997
Intermittent continuous infusion of fluorouracil and low-dose oral leucovorin in pretreated breast cancer: a pilot studyM Colleoni, G Vicario, P Nelli, et al.
Oncology Reports|May 20, 2011
Weekly carboplatin in elderly patients with advanced ovarian cancerM Colleoni, G Sgarbossa, P Nelli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 29, 1998
Adjuvant chemoendocrine therapy in postmenopausal breast cancer: cyclophosphamide, methotrexate, and fluorouracil dose and schedule may make a difference. International Breast Cancer Study GroupA Goldhirsch, A S Coates, M Colleoni, et al.
Journal of Cellular Biochemistry|August 31, 2001
Nitroxide TEMPOL impairs mitochondrial function and induces apoptosis in HL60 cellsE Monti, R Supino, M Colleoni, et al.
Tumori|August 31, 1992
Reversal of resistance to doxifluridine and fluorouracil in metastatic colorectal cancer: the role of high-dose folinic acidM Colleoni, E Bajetta, F de Braud, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 8, 1998
Adding adjuvant CMF chemotherapy to either radiotherapy or tamoxifen: are all CMFs alike? The International Breast Cancer Study Group (IBCSG)A Goldhirsch, M Colleoni, A S Coates, et al.
Pageof 18